This release presents an integrated medical and veterinary systems-engineering architecture developed within the Boundary and Continuity Science research programme. It formalizes the preservation of safety, evidence, identity, responsibility, clinical continuity, recoverability, and future intervention possibilities across human, animal, technical, and institutional systems. The package combines a finite architectural inventory with an executable, non-actuating living evidence system designed to support research reproducibility, structured safety review, provenance assessment, and future incorporation of independently verified findings. The finite architecture contains: 99 foundational requirements, comprising 72 inherited and 27 additional records. 132 system capabilities, comprising 96 inherited and 36 additional records. 117,612 unique nine-direction coordinates, generated from the 99 × 132 × 9 declared classification. 16 explicit missing-dependency records, identifying unresolved clinical, technical, operational, and regulatory requirements. The nine analysis directions encompass inward, outward, upward, downward, lateral, backward, forward, adversarial, and recursive investigation. The medical and veterinary scope includes organ-specific care architectures, neonatal and pediatric safeguards, developmental medicine, comparative physiology, hereditary history, oncology continuity, emergency care, medical-device safety, and One Health coordination. The living software layer implements a local append-only evidence ledger, hash-linked events, provenance preservation, timestamp and schema validation, duplicate detection, evidence review, and safety-triggered reopening of previously closed architectural classifications. An optional operator-initiated public-source retrieval component supports controlled evidence updates. No continuously running external data service, hospital integration, individual patient monitoring, veterinary telemetry, or medical-device actuation is claimed. The package retains the preceding v26 archive as an unchanged nested ZIP, preserving the previous release lineage. Seventeen offline software tests are recorded as passing. These tests establish limited software consistency and safeguard behavior; they do not establish clinical efficacy or device certification. The architecture adopts a Threshold Non-Circular Separate Final Closure condition: additional formal combinations are not treated as new validated capabilities unless they introduce independently supported differences in protection, clinical outcomes, evidence, risk, responsibility, timing, or recoverability. The finite classification is closed within its declared scope, while the living architecture remains open to new evidence, verified prototypes, safety findings, and regulatory developments. Intended applications: Systems-engineering research, medical and veterinary informatics, evidence governance, patient-safety research, software verification, educational use, and future independently validated healthcare technologies. Limitations: This is not a clinically certified medical device, autonomous diagnostic system, validated universal treatment, or demonstrated cure for human or animal diseases.
No takes yet. Share an insight, caveat, or question.
Noelia Sanchez (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: